Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention (CDC), 20354-20355 [2011-8657]
Download as PDF
<![CDATA[
20354
Federal Register / Vol. 76, No. 70 / Tuesday, April 12, 2011 / Notices
Daniel Holcomb,
Reports Clearance Officer, Centers for Disease
Control and Prevention.
critical areas of applied public health
epidemiology, public health laboratory
science and public health informatics.
[FR Doc. 2011–8650 Filed 4–11–11; 8:45 am]
Reporting Requirements
BILLING CODE 4163–18–P
Recipients of the ACA funds through
this funding opportunity are required to
comply with the reporting requirements,
terms and conditions set forth in the
published version of Funding
Opportunity CDC–RFA–HM10–1001.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Award Information:
Notice of Intent To Award
Supplemental Affordable Care Act
Funding
Notice of Intent to award
supplemental Affordable Care Act
funding to support enhancement of an
existing laboratory fellowship training
program through funding opportunity
CDC–RFA–HM10–1001, ‘‘APHL—CDC
Partnership for Quality Laboratory
Practice’’ cooperative agreement.
AGENCY: Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice.
This notice provides public
announcement of CDC’s intent to use
Affordable Care Act (ACA)
appropriations to expand the Emerging
Infectious Diseases (EID) Laboratory
Fellowship Program currently
supported through Funding
Opportunity CDC–RFA–HM10–1001,
‘‘APHL–CDC Partnership for Quality
Laboratory Practice.’’ Funding is
appropriated under the Affordable Care
Act (Pub. L. 111–148), Title IV, Section
4002 (Prevention and Public Health
Fund). In addition, Under Section 5314,
Fellowship Training in Public Health
(Part E of title VII of the Public Health
Service Act (42 U.S.C. 294n et seq., as
amended by section 5206, is further
amended by Sec. 778), CDC is
authorized to expand existing
fellowship training programs in the
critical areas of applied public health
epidemiology, public health laboratory
science and public health informatics.
The CFDA Number for this funding
opportunity is 93.065.
CDC will add the following ACA
Authority to that which is reflected in
the published Funding Opportunity
CDC–RFA–HM10–1001:
srobinson on DSKHWCL6B1PROD with NOTICES
SUMMARY:
Authority: Funding is appropriated under
the Affordable Care Act (Pub. L. 111–148),
Title IV, Section 4002 (Prevention and Public
Health Fund). In addition, Under Section
5314, Fellowship Training in Public Health
(Part E of title VII of the Public Health
Service Act (42 U.S.C. 294n et seq., as
amended by section 5206, is further amended
by Sec. 778), CDC is authorized to expand
existing fellowship training programs in the
VerDate Mar<15>2010
18:00 Apr 11, 2011
Jkt 223001
Type of Award: Cooperative
Agreement.
Approximate Current Fiscal Year
Funding: $1,000,000 in Affordable Care
Act (ACA) Funding.
Anticipated Number of Awards: 1.
Anticipated Award Date: July 1, 2011.
Fiscal Year Funds: 2011.
DATES: The effective date for this action
is April 12, 2011 and remains in effect
until the expiration of the project period
of the PPHF ACA funded application.
FOR FURTHER INFORMATION CONTACT:
Elmira Benson, Acting Deputy Director,
Centers for Disease Control and
Prevention, 2920 Brandywine Road,
Atlanta, GA 30341, telephone (770)
488–2802, e-mail
Elmira.Benson@cdc.gov.
On March
23, 2010, the President signed into law
the Affordable Care Act (ACA), Public
Law 111–148. ACA is designed to
improve and expand the scope of health
care coverage for Americans. Cost
savings through disease prevention is an
important element of this legislation
and ACA has established a Prevention
and Public Health Fund (PPHF) for this
purpose. Specifically, the legislation
states in Section 4002 that the PPHF is
to ‘‘provide for expanded and sustained
national investment in prevention and
public health programs to improve
health and help restrain the rate of
growth in private and public sector
health care costs.’’ In addition, under
Section 5314, Fellowship training in
public health (Part E of title VII of the
Public Health Service Act (42 U.S.C.
294n et seq., as amended by section
5206, is further amended by Sec. 778),
CDC is authorized to expand existing
fellowship training programs in the
critical areas of applied public health
epidemiology, public health laboratory
science and public health informatics.
Supplemental ACA funding, as
referenced in this notice, will enhance
the work of national, state and local
public health laboratories in the U.S.
through expansion of the Emerging
Infectious Diseases (EID) Laboratory
Fellowship Program. The EID
Fellowship, sponsored by the
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
Association of Public Health
Laboratories (APHL) and CDC and
funded through a cooperative agreement
with APHL, trains and prepares
scientists for careers in public health
laboratories and supports public health
initiatives related to infectious disease
research. The program aims to promote
quality public health laboratory
practice, improve public health
laboratory infrastructure, strengthen the
public health laboratory system, and
develop a well-trained public health
laboratory workforce. Activities that
promote the development of a welltrained public health laboratory
workforce are outlined in section 10 of
the cooperative agreement. Therefore,
the programmatic activities CDC
proposes to support with these ACA
funds are consistent with the intent of
the Affordable Care Act and Prevention
and Public Health Fund (PPHF), Section
4002.
Dated: March 25, 2011.
Tanja Popovic,
Deputy Associate Director for Science,
Centers for Disease Control and Prevention.
[FR Doc. 2011–8651 Filed 4–11–11; 8:45 am]
BILLING CODE P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Committee to the Director
(ACD), Centers for Disease Control and
Prevention (CDC)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned committee.
Time and Date: 1 p.m.–3:05 p.m., April 28,
2011.
Place: The meeting will be held by
teleconference. Please dial 877–930–8819
and enter code 1579739.
Status: Open to the public, limited only by
the lines available. The public is welcome to
participate during the public comment
period. The public comment period is
tentatively scheduled for 2:55 p.m. to 3 p.m.
Purpose: The committee will provide
advice to the CDC Director on strategic and
other broad issues facing CDC.
Matters to Be Discussed: The Advisory
Committee to the Director will review and
discuss recommendations and reports from
two subcommittees and one workgroup. The
Ethics Subcommittee will submit
recommendations on Ethical Considerations
for Non-communicable Disease Interventions
as well as on Ethical Considerations for
Decision Making Regarding Allocation of
Mechanical Ventilators during a Severe
E:\FR\FM\12APN1.SGM
12APN1
Federal Register / Vol. 76, No. 70 / Tuesday, April 12, 2011 / Notices
Influenza Pandemic or Other Public Health
Emergency. The National Biosurveillance
Advisory Subcommittee will submit their
report entitled, ‘‘Improving the Nation’s
Ability to Detect and Respond to 21st
Century Urgent Health Threats: Second
Report of the National Biosurveillance
Advisory Subcommittee,’’ for approval. The
State, Tribal, Local and Territorial (STLT)
Workgroup will provide Directional
Recommendations for Enhancing CDC
Support to the STLT Community.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Carmen Villar, MSW, Designated Federal
Officer, ACD, CDC, 1600 Clifton Road, NE.,
Mailstop D–14, Atlanta, Georgia 30333,
Telephone: (404) 639–7000. E-mail:
GHickman@cdc.gov. The deadline for
notification of attendance is April 25, 2011.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Research in Thailand by the Ministry of
Public Health (MOPH) (U01),’’ FOA GH11–
002, initial review.
Contact Person for More Information:
Susan B. Stanton, D.D.S., Scientific Review
Officer, CDC, 1600 Clifton Road, NE.,
Mailstop D–72, Atlanta, Georgia 30333,
Telephone: (404) 639–4640.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: April 5, 2011.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention (CDC).
Centers for Disease Control and
Prevention
[FR Doc. 2011–8657 Filed 4–11–11; 8:45 am]
BILLING CODE 4163–18–P
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Funding
Opportunity Announcement (FOA),
Initial Review
srobinson on DSKHWCL6B1PROD with NOTICES
The meeting announced below
concerns ‘‘Conducting Public Health
Research in Thailand by the Ministry of
Public Health (MOPH) (U01),’’ FOA
GH11–002, initial review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date: 1 p.m.–4 p.m., May 26,
2011 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters to be Discussed: The meeting will
include the initial review, discussion, and
evaluation of applications received in
response to ‘‘Conducting Public Health
18:00 Apr 11, 2011
Jkt 223001
[FR Doc. 2011–8659 Filed 4–11–11; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Funding
Opportunity Announcement (FOA)
DD11–009, Initial Review
The meeting announced below
concerns ‘‘Public Health Research for
the Prevention of Complications of
Bleeding,’’ FOA DD11–009, initial
review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
VerDate Mar<15>2010
Dated: April 5, 2011.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
Time and Date: 10 a.m.–5 p.m., May 19,
2011 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters to be Discussed: The meeting will
include the initial review, discussion, and
evaluation of applications received in
response to ‘‘Public Health Research for the
Prevention of Complications of Bleeding,’’
FOA DD11–009, initial review.
Contact Person for More Information:
Michael Dalmat, Dr.PH., Scientific Review
Officer, Extramural Research Program Office,
National Center for Chronic Disease
Prevention and Health Promotion, CDC, 4770
Buford Highway, NE., Mailstop K–92,
Atlanta, Georgia 30341, Telephone: (770)
488–6423, E-mail: MED1@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
20355
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: April 5, 2011.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2011–8658 Filed 4–11–11; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Funding
Opportunity Announcement (FOA),
Initial Review
The meeting announced below
concerns Muscular Dystrophy
Surveillance Tracking and Research
Network (MD STARnet); Feasibility of
Expansion to Other Muscular
Dystrophies (FOA) DD11–006, initial
review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date: 11 a.m.–5 p.m., May 10,
2011 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the initial review, discussion, and
evaluation of applications received in
response to ‘‘Muscular Dystrophy
Surveillance Tracking and Research Network
(MD STARnet); Feasibility of Expansion to
Other Muscular Dystrophies (FOA) DD11–
006, initial review.’’
Contact Person for More Information:
Brenda Colley Gilbert, Ph.D., M.P.H.,
Director, Extramural Research Program
Office, National Center for Chronic Disease
Prevention and Developmental Disabilities,
CDC, 1600 Clifton Road, NE., Mailstop K92,
Atlanta, Georgia 30333, Telephone: (770)
488–6295.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
E:\FR\FM\12APN1.SGM
12APN1
]]>Agencies
[Federal Register Volume 76, Number 70 (Tuesday, April 12, 2011)]
[Notices]
[Pages 20354-20355]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-8657]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Committee to the Director (ACD), Centers for Disease
Control and Prevention (CDC)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting of the aforementioned
committee.
Time and Date: 1 p.m.-3:05 p.m., April 28, 2011.
Place: The meeting will be held by teleconference. Please dial
877-930-8819 and enter code 1579739.
Status: Open to the public, limited only by the lines available.
The public is welcome to participate during the public comment
period. The public comment period is tentatively scheduled for 2:55
p.m. to 3 p.m.
Purpose: The committee will provide advice to the CDC Director
on strategic and other broad issues facing CDC.
Matters to Be Discussed: The Advisory Committee to the Director
will review and discuss recommendations and reports from two
subcommittees and one workgroup. The Ethics Subcommittee will submit
recommendations on Ethical Considerations for Non-communicable
Disease Interventions as well as on Ethical Considerations for
Decision Making Regarding Allocation of Mechanical Ventilators
during a Severe
[[Page 20355]]
Influenza Pandemic or Other Public Health Emergency. The National
Biosurveillance Advisory Subcommittee will submit their report
entitled, ``Improving the Nation's Ability to Detect and Respond to
21st Century Urgent Health Threats: Second Report of the National
Biosurveillance Advisory Subcommittee,'' for approval. The State,
Tribal, Local and Territorial (STLT) Workgroup will provide
Directional Recommendations for Enhancing CDC Support to the STLT
Community.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Carmen Villar, MSW,
Designated Federal Officer, ACD, CDC, 1600 Clifton Road, NE.,
Mailstop D-14, Atlanta, Georgia 30333, Telephone: (404) 639-7000. E-
mail: GHickman@cdc.gov. The deadline for notification of attendance
is April 25, 2011.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Dated: April 5, 2011.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention (CDC).
[FR Doc. 2011-8657 Filed 4-11-11; 8:45 am]
BILLING CODE 4163-18-P
